Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

News

Archive

Finally, Graphene electronic devices available for all Ventyx Biosciences reports clinical data for its NLRP3 inhibitor portfolio and provides pipeline updates at virtual investor event NorthSea Therapeutics initiates Phase 2A trial of Orziloben (NST-6179) in Intestinal Failure-Associated Liver Disease (IFALD) Resolve Therapeutics announces publication of Lupus clinical trial results biomodal delivers the 6-base genome with a powerful new multiomic solution, duet evoC InvestEU in Belgium: EIB venture debt for bone therapy innovator Novadip
Back To News
BrightVolt expands R&D capabilities with new equipment
April 5, 2018

BrightVolt expands R&D capabilities with new equipment

arbin-logo

In Q1 of 2018 BrightVolt added technical personnel and made a substantial investment in new equipment to enhance our solid state battery development. This will help us improve the energy density and performance of our new solid state rechargeable batteries. BrightVolt’s first rechargeable batteries are expected to debut in Q3 of this year.

Our new solid state rechargeable battery product line will benefit from a new Keyence Digital Microscope, a new Metrohm Microcell HD, an additional Arbin 128 channel battery test system, and a new Branson ultrasonic welder. 

Cookie Policy Privacy Policy